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Summary 
The effect of the a-glucosidase inhibitor acarbose on retinal capillary basement membrane thickening 
was examined in the spontaneously diabetic BB/W-rat. Four months of diabetes resulted in significant 
thickening of the basement membranes of both the superficial and deep capillary nets of the retina. This 
characteristic change of the retinal microvasculature in diabetes was completely prevented by acarbose 
treatment that substantially reduced postprandial hyperglycemia. A similar but less pronounced effect was 
seen on the age-related increase in basement membrane thickening in acarbose-treated non-diabetic control 
rats who demonstrated decreased glycated hemoglobin levels compared to non-treated control rats. Signili- 
cant positive correlations between basement membrane thickness and glycated hemoglobin area suggest 
that diabetic retinal microangiopathy may be prevented by lowering the cumulative glucose exposure to 
the microvasculature, and that age-related basement membrane thickening is mediated by long-term 
exposure to normal glucose levels. 
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Introduction 
Cumulative hyperglycemia is probably the most 
important risk factor in the development of 
secondary diabetic complications [ 1,2]. During 
hyperglycemia glucose levels in the target organs 
of diabetic complications equilibriate with those of 
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ambient plasma levels, since glucose uptake in 
these tissues is insulin independent [3]. Lowering 
of cumulative glucose exposure to these target 
tissues may therefore ameliorate the metabolic, 
functional and structural consequences of hyper- 
glycemia [4]. This hypothesis was tested in the 
present study in which diabetic BB/W-rats were 
treated with the o-sucrose inhibitor acarbose. This 
compound is a potent competitive inhibitor of 
small intestine o-glucosidase. It delays the genera- 
tion of monosaccharides in the gut and suppresses 
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significantly postprandial elevations in blood glu- 
cose and insulin responses in the rat and man 
[4-71. 
We tested the effect of this compound on the 
characteristic basement membrane thickening 
(BMT) of the retinal microvasculature in the 
diabetic BBW-rat and on the normal age-related 
increases in BMT in non-diabetic BB/W-rats. 
Material and Methods 
Animals 
Twelve pre-diabetic male BB/W-rats, and 12 
age- and sex-matched non-diabetes-prone BB/W- 
rats were obtained from the National Institutes of 
Health (NIH) BB-rat colony at the University of 
Massachusetts (Worcester, MA). At the onset of 
diabetes, detected by glucosuria (Test Tape, Eli 
Lilly Canada Inc., Toronto, Ont.), rats were com- 
menced on small daily titrated doses of protamine 
zinc insulin (Connaught-Novo Inc., Toronto, 
Ont.) in order to prevent ketoacidosis. Six diabetic 
and 6 non-diabetic control rats were given free ac- 
cess to rat chow (Lab Blox F-6, Wayne Animal 
Diets, Winnipeg, Manitoba) and water. The re- 
maining 6 diabetic and 6 control rats were given 
rat chow mixed with 20 mg acarbose/lOO g rat 
chow (BAY g 5421, Miles Inc., West Haven, CT) 
equivalent to a minimal dose of 5 mg/kg body 
weight. All rats were kept in air filtered metabolic 
cages with a 12-h light cycle. 
Clinical monitoring 
Body weight, urine volume, and glucosuria were 
monitored daily. Blood glucose was measured 
weekly from tail-vein blood samples using an 
Ames Eyetone (Miles Laboratories Ltd., Rexdale, 
Ont.). In order to obtain 24-h glucose profiles, un- 
treated and acarbose-treated diabetic rats were 
monitored as to blood sugar levels every 2 h for 
four 24-h cycles. Glycated hemoglobin levels were 
measured every month using an affinity chroma- 
tography test kit (Glyco-Test, Pierce Chemical 
Co., Rockford, IL). For each individual animal 
the glycated Hb area under the curve was 
calculated as a measure of cumulative hyperglyce- 
mia during the observation period. The normal 
glycated Hb was arbitrarily set to 1000/o and indi- 
vidual values were expressed as a percentages 
thereof. 
Tissue collection 
Animals were anesthetized with intra-peritoneal 
injections of Na-pentobarbitol and sacrificed by 
whole body perfusion with 2.5”/ glutaraldehyde in 
0.1 M Na-cacodylate buffer (pH 7.4). From the left 
eye the posterior eyecup was dissected within 3 
mm of the optic nerve head and fixed in the same 
fixative for 4 h at 4°C. The tissues were post-fixed 
in Na-cacodylate buffered 1 o/;) osmic tetroxide (pH 
7.4) for 2 h at 4°C dehydrated and embedded in 
Epon. Ultrathin sections cut perpendicular to the 
retinal surface were stained with aqueous uranyl 
acetate and lead citrate and examined electron 
microscopically as previously described (81. 
Morphometric techniques 
Electronmicrographs with a total magnification 
of 25 000 times were used for the capillary base- 
ment membrane (BM) measurements. From each 
retina 10 randomly selected, transversely sectioned 
capillaries from each the superficial and the deep 
capillary beds were investigated. BMT was 
measured with the aid of a Hewlett Packard 9874A 
digitizer interfaced with a Hewlett Packard 9875A 
computer (Hewlett Packard, Fort Collins, CO) as 
previously described in detail [9]. Briefly, the total 
capillary area was measured, BM area was deter- 
mined by subtracting lumenal, endothelial cell, 
and pericyte areas from the total area. Mean BM 
length was calculated by measuring the lengths of 
the lines delineating the BM divided in half. BMT 
was expressed as area per unit length (nm). This 
method takes into account the variability of the 
BM contour and gives an average value of BMT. 
Statistical analysis 
The data are expressed as means f S.E.M. and 
were analyzed by one-way analysis of variance and 
linear contrast. Linear regression analyses were 
performed using the least square method. 
Results 
Clinical observations 
Acarbose-treated and non-treated diabetic rats 
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TABLE I 
Comparisons of body weight, blood glucose, glycated hemoglobin, glycated hemoglobin area, and basement membrane thickness in 
the two capillary nets between acarbose-treated diabetic and control rats, and non-treated diabetic and control rats” 
Basement membrane thickness 
(run) 














(n = 6) 
Acarbose-treated 
control rats 
(n = 6) 
Non-treated 
diabetic rats 
(n = 6) 
Acarbose-treated 
diabetic rats 
(n = 6) 
451 f I 4.7 f 0.6 4.5 f 0.4e 100.0 f 4.5s 122.7 zt S.Zh 72.0 zt 2.gh 
439 l 9 5.6 zt 0.4 3.8 LIZ 0.2 73.1 f 2.4 92.6 * 6.2’ 57.9 f 2.3’ 
365 f 6b 17.8 f 3.0b 9.8 zt 0.6’,’ 160.7 f 3.4b.d 117.6 f 5.5b,d 105.1 l 4.lb.d 
383 l 13b 13.8 f 0.6b 7.2 zt 0.3’ 127.9 f 2.9’ 113.0 f 6.1 72.4 l 6.8 
a Values are means l S.E.M. of n = 6 in each group. 
b P < 0.001 compared to non-treated control rats or acarbose-treated control rats. 
’ P < 0.001 compared to acarbose-treated control rats. 
d P < 0.001 compared to acarbose-treated diabetic rats. 
e P < 0.01 compared to non-treated diabetic rats or acarbose-treated diabetic rats. 
’ P < 0.05 compared to acarbose-treated diabetic rats. 
g P < 0.001 compared to acarbose-treated control rats. 
h P < 0.05 compared to acarbose-treated control rats. 
’ P < 0.02 compared to acarbose-treated diabetic rats. 
J P < 0.05 compared to acarbose-treated diabetic rats. 
showed hyperglycemia, elevated glycated hemo- 
globin levels, and decreased body weights when 
compared to treated and non-treated control rats 
(Table 1). Although single blood glucose 
measurements at 1500 h did not reveal any signifi- 
cant differences between acarbose treated and 
non-treated diabetic rats (Table l), the 24 h blood 
glucose area in acarbose-treated diabetic rats was 
significantly decreased by 40% as previously 
reported [4]. This decrease was reflected in a signi- 
ficant (P < 0.001) lowering of the glycated hemo- 
globin area during the study period in 
acarbose-treated diabetic rats (Table 1 and Fig. 1). 
Acarbose-treatment of non-diabetic control rats 
resulted in a 27”/0 significant (P < 0.001) decrease 
in glycated hemoglobin area as compared to non- 
treated control rats (Table 1 and Fig. 1). Acarbose 
treatment was well tolerated by treated animals 
who showed no weight loss or increased frequency 
of diarrhea. 
Effect on BMT 
The BMT of both the superficial and deep capil- 
lary nets were significantly increased in non- 
treated diabetic BB/W-rats (Table 1 and Fig. 2). 
This increase in BMT was completely prevented by 
acarbose-treatment of diabetic rats (Table 1 and 
Fig. 2). In control rats acarbose-treatment had a 
small but statistically significant (P c 0.05) effect 
on the presumably age-related BM thickening [lo] 
(Table 1). Highly significant correlations were 
obtained between glycated hemoglobin areas and 
BMT of the superficial and the deep capillary net 
(Fig. 3). 
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Fig. 1. As a measure of cumulative hyperglycemia, the areas under the curve formed by monthly glycated Hb-measurements was 
employed. n , diabetic rats, n = 6; 0, acarbose-treated diabetic rats, n = 6: 0. control rats, n = 6; 0. acarbose-treated control rats. 
n = 6. 
50 100 150 200 
Glycated Hb area (percent of normal) 
Fig. 2. Electronmicrographs comparing BMT in the deep capil- 
lary net in (a) non-treated control rat, (b) non-treated diabetic 
rat, and (c) acarbose-treated diabetic rat. Mag. x 25 000. 
Fig. 3. Regression analyses between glycated Hb area and BMT 
in the superficial capillary net (0) and the BMT of the capil- 
laries in the deep net (0). The points are group 
means * S.E.M. and each point represents 6 animals. Regres- 
sion for the superficial BMT showed: r = 0.69. n = 24, P < 
0.001; for the deep capillary BMT: r = 0.78. n = 24. P < 0.001. 
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Discussion 
In the present communication we have 
demonstrated that successful lowering of post- 
prandial hyperglycemia resulting in decreased 
cumulative hyperglycemia in diabetic BB/W rats 
prevents the characteristic BMT in retinal capil- 
laries. The pathophysiology of BMT in diabetes 
and aging is not known in detail [l 11. It has been 
suggested that non-enzymatic glycation of extra- 
cellular matrix constituents such as various col- 
lagen species and Iibronectin may play a major 
role in altering the physiochemical and permeabili- 
ty properties of BMs [12,13]. Decreased synthesis 
of proteoglycans and subsequent deprivation of 
anionic sites probably affects the charge selective 
BM barrier function [14] and is accompanied by 
an enhanced collagen IV gene expression and in- 
creased production of matrix proteins [15,16]. 
However, fructose which is secondarily elevated in 
diabetes via the polyol pathway may be more im- 
portant than glucose itself in explaining BMT. 
Fructose possesses a multifold higher affinity to 
bind non-enzymatically to proteins and promote 
subsequent cross-linkages [ 17- 191. The fact that 
the polyol pathway is localized to both endothelial 
cells and pericytes of retinal capillaries [20] and 
that aldose reductase inhibition prevents BMT in 
retinal capillaries in the presence of hyperglycemia 
lends further credence to this notion [8,21,22]. 
Hence, the effect of acarbose on retinal capillary 
BMT could be mediated by a decreased cumula- 
tive exposure of the microvasculature to glucose 
per se, and/or by lowered local fructose concentra- 
tions mediated by a decreased activity of the 
polyol-pathway secondary to decreased hyper- 
glycemia. 
Structural abnormalities characteristic of 
diabetic neuropathy which are more closely linked 
to the activation of the polyol-pathway are 
significantly ameliorated following acarbose treat- 
ment [4], suggesting that this pathway is indeed 
deactivated by the present treatment regimen. It is 
conceivable that elimination of pronounced 
postprandial hyperglycemia by acarbose [4] is 
sufficient to inhibit the induction of aldose reduc- 
tase [23], despite the fact the cumulative hypergly- 
cemia in acarbose treated diabetic rats exceeded 
that of non-diabetic control rats. 
An unexpected finding in the present study was 
the significant attenuation of the age-related BMT 
in acarbose-treated non-diabetic control rats most 
likely due to decreased ambient glucose levels as 
reflected by a significant decrease in glycated 
hemoglobin area compared to non-treated control 
rats. It is unlikely that other nutritional factors 
would be responsible for this finding, since 
acarbose-treated control rats showed no weight 
loss or increased frequency of diarrhea compared 
to non-treated control rats. 
In summary the present findings suggest that 
suppression of the cumulative glucose load has an 
attenuating effect on the development of the 
characteristic BMT of retinal capillaries associated 
with diabetes and normal aging. 
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